Oryzon Genomics' stock rose over 3% after announcing progress in a leukemia study. The first patient received a dose in a Phase Ib trial of iadademstat...
Stem cells have been used in successful cancer treatment, particularly in leukemia patients. Here's how it works.
Leukemia is very challenging to treat. But with two new discoveries, it can now be screened and managed at an earlier time.
Hemogenyx Pharmaceuticals Ltd. will start trading on the London Stock Exchange under the ticker symbol HEMO on Thursday, October 5, 2017.